Results 11 to 20 of about 9,004,370 (343)
Archives of Disease in Childhood, 1985 We report five children who presented with Raynaud's disease in whom we could find no clinical, haematological, or immunological evidence of a collagen disorder. Oral phenoxybenzamine proved useful for maintenance treatment in most, with infusions of prostacyclin, nitroprusside, and ketanserin during acute attacks.
David B. Dunger, M J Dillon, E. C. Burns
openaire +4 more sources
Phosphodiesterase Type 5 Inhibition Is a Novel Therapeutic Option in Raynaud Disease [PDF]
Archives of Internal Medicine, 2006 BACKGROUND Raynaud disease (RD) is a common disorder affecting 3% to 5% of the healthy population, and occurs in more than 90% of patients with connective tissue diseases. The therapeutic options remain limited, particularly in patients with secondary RD
Evren Caglayan +7 more
openalex +2 more sources
Mechanisms of Raynaud’s disease [PDF]
Vascular Medicine, 2005 Raynaud's phenomenon is due to transient cessation of blood flow to the digits of the hands or feet. An attack of Raynaud’s phenomenon is classically manifested as triphasic color changes. The white phase is due to excessive vasoconstriction and cessation of regional blood flow.
John P. Cooke, Janice M. Marshall
openaire +4 more sources
Effect of Indoramin on Finger Circulation in Patients with Raynaud Disease
Journal of Cardiovascular Pharmacology, 1986 D Clément, Daniel Duprez, N. De Pue
openalex +2 more sources
Prevalence of Raynaud Phenomenon and Nailfold Capillaroscopic Abnormalities in Fabry Disease
Medicine, 2015 Fabry disease (FD) is a lysosomal disorder leading to progressive systemic involvement, including microvascular damage that leads to neurological and cardiovascular disorders.
Samuel Deshayes +8 more
openalex +2 more sources
ACR Open Rheumatology, 2023 Objective To better understand the symptoms and impacts of Raynaud phenomenon (RP) in patients with systemic sclerosis (SSc) and to evaluate the content validity and usability of a new electronic patient‐reported outcome (PRO) measure for RP: the Raynaud
Robyn T. Domsic +13 more
doaj +1 more source
Dystrophic calcifications and Raynaud’s phenomenon in an eight-year old girl [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2014 Introduction. Dystrophic calcifications are the most common subtype of skin calcinosis. Tumorous soft tissue calcium deposits usually contain hydroxyapatite and amorphous calcium phosphate.
Grebeldinger Slobodan P. +5 more
doaj +1 more source
Osteonecrosis of carpal bones in systemic sclerosis [PDF]
Romanian Journal of Rheumatology, 2021 Background. Systemic sclerosis (SSc) is a rare chronic disease, with unknown aetiology and complex pathogenesis. The hand is often implied in the main clinical findings, being affected primarily by the vascular component (Raynaud phenomenon, digital ...
Alexandra Chitac, Codrina Ancuta
doaj +1 more source
Raynaud’s Phenomenon with Focus on Systemic Sclerosis
Journal of Clinical Medicine, 2022 Raynaud’s phenomenon is a painful vascular condition in which abnormal vasoconstriction of the digital arteries causes blanching of the skin. The treatment approach can vary depending on the underlying cause of disease.
M. Maciejewska +5 more
semanticscholar +1 more source